New rabies vaccine shows promise in preventing deadly infection
NCT ID NCT04594551
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This Phase 3 trial tested a new rabies vaccine (VRVg-2) in 201 healthy adults in Thailand. Participants received the vaccine along with rabies antibodies, mimicking post-exposure treatment. The study measured immune response and safety, finding that the vaccine triggered protective antibody levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Purified vero rabies vaccine - serum free (VRVg-2)
What this could lead to
If successful, this could provide a safer, effective rabies vaccine option for post-exposure prevention.
What could go wrong
This is a completed Phase 3 trial in healthy adults, not actual rabies patients. Real-world effectiveness and safety in infected individuals may differ.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site number 7640001
Bangkok, 10400, Thailand
-
Investigational site number 7640002
Bangkok, 10330, Thailand
-
Investigational site number 7640003
Bangkok, 10700, Thailand